COVID-19 Vaccine Policy Shifts Amid Rising Cases and Fears of Eroding Trust in Vaccines
Amidst the growing surge in COVID-19 cases driven by the "stratus" variant, the U.S. government has announced new restrictions on who is eligible for COVID vaccines, sparking concerns about public health and vaccine safety. Health Secretary Robert F. Kennedy Jr. has rescinded emergency use authorizations for Pfizer and Moderna mRNA shots, leaving pharmacists unable to dispense vaccines without a doctor's approval. The new rules also mean that patients under 65 with no underlying health conditions are no longer eligible for the updated Pfizer booster, Comirnaty.
Key Takeaways:
- The FDA has approved updated boosters for high-risk patients, but the new policy restricts vaccine eligibility for those under 65 without underlying health conditions.
- Health Secretary Robert F. Kennedy Jr. has rescinded emergency use authorizations for Pfizer and Moderna mRNA shots, citing concerns about vaccine safety.
- Patients under 65 with no underlying health conditions are no longer eligible for the updated Pfizer booster, Comirnaty.
- The Centers for Disease Control and Prevention (CDC) has approved the Pfizer-BioNTech COVID vaccine for adults 65 years old and up, including seniors, but the approval is still under review for children under 5.
- Insurance coverage for COVID vaccines is unclear, with some insurers stating that they will continue to provide coverage, but the details are still forthcoming.
- Children under 5 are still eligible for off-label prescriptions for the Pfizer vaccine, and the Moderna vaccine is approved for children as young as 6 months old.
- Pharmacists are no longer permitted to dispense vaccines without a doctor's approval.
Statistics:
- The number of COVID-19 cases has surged across the country, driven by the "stratus" variant.
- The "stratus" variant has spread to disproportionately affect high-risk populations.
- 140 is the estimated cost per vaccination shot, according to the CDC.
- The CDC has approved the Pfizer-BioNTech COVID vaccine for adults 65 years old and up, including seniors.
- The number of underlying health conditions for eligibility is quite broad, including asthma, heart conditions, depression, physical inactivity, smoking, and obesity.
Sources:
- [https://www.axios.com/2025/08/27/covid-19-vaccine-policy-cases-rise](https://www.axios.com/2025/08/27/covid-19-vaccine-policy-cases-rise)
- [https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html](https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html)
- [https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontechs-comirnatyr-receives-us-fda-approval?cid=em_PfizerNewsroomAlert&ttype=em](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontechs-comirnatyr-receives-us-fda-approval?cid=em_PfizerNewsroomAlert&ttype=em)
- [https://www.cdc.gov/vaccines-for-children/php/awardees/current-cdc-vaccine-price-list.html](https://www.cdc.gov/vaccines-for-children/php/awardees/current-cdc-vaccine-price-list.html)
- [https://apnews.com/article/vaccines-covid-shots-fda-kennedy-pfizer-children-9ce19908ae7afb354732aa162fd28532](https://apnews.com/article/vaccines-covid-shots-fda-kennedy-pfizer-children-9ce19908ae7afb354732aa162fd28532)